Enhancement of caffeine-induced locomotor hyperactivity produced by combination with L-arginine or taurine in mice: Possible involvement of nitric oxide

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 31, Issue 9, 2009, Pages 585-589

  Kimura, M ^a   Ushijima, I ^a   Hiraki, M ^a   Ono, Nobufumi ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Caffeine; Combinations; L Arginine; L NAME; Locomotor activity; Nitric oxide; Taurine

Indexed keywords

ARGININE; CAFFEINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; TAURINE;

ANIMAL EXPERIMENT; ARTICLE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG INHIBITION; DRUG POTENTIATION; EVOKED MUSCLE RESPONSE; LOCOMOTION; MALE; MOLECULAR MECHANICS; MOTOR ACTIVITY; MOUSE; NONHUMAN;

ANIMALS; ARGININE; CAFFEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICE; MOTOR ACTIVITY; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; TAURINE;

EID: 75749137389     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.2009.31.9.1435462     Document Type: Article

References (29)

1. Olive, M.F. Interactions between taurine and ethanol in the central nervous system. Amino Acids 2002, 23: 345-57.
2. Warburton, D.M., Bersallini, E., Sweeney, E. An evaluation of a caffeinated taurine drink on mood, memory and information processing in health volunteers without caffeine abstinence. Psychopharmacology 2001, 158: 322-8.
3. Moncada, S., Higgs, A., Furchigott, R. International union of pharmacology nomenclature in nitric oxide research. Pharmacol Rev 1997, 49: 137-42.
4. 2A receptors in the carotid body and nucleus tractus solitarius of adult male and female rats following neonatal caffeine treatment. Brain Res 2009, 1287: 74-83.
5. Kayir, H., Uzbay, I.T. Evidence for the role of nitric oxide in caffeine-induced locomotor activity in mice. Psychopharmacology 2004, 172: 11-15.
6. 2A receptors. Br J Pharmacol 2000, 129: 1465-73.
7. Snyder, S.H., Kafuns, J.J., Annau, Z., Bruns, R.F., Daly, J.W. Adenosine receptors and behavioral actions of methylenexanthines. Proc Natl Acad Sci 1981, 78: 3260-4.
8. Celik, T., Zagli, U., Kayir, H., Uzbay, I.T. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend 1999, 56: 109-13.
9. L- arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride. Eur J Pharmacol 2007, 569: 77-83.
10. L-arginine supplementation on NO production in man. Eur J Clin Pharmacol 2006, 62: 91-9.
11. 1 mRNA in mouse brain: Effect of long-term caffeine treatment. Brain Res 1997, 762: 153-64.
12. 1 receptors, using in vivo and in vitro techniques. J Pharmacol Exp Ther 1998, 285: 1023-30.
13. Dunwiddie, T.V., Masino, S.A. The role and regulation of adenosine in the central nervous system. Annu Rev Neutosci 2001, 24: 31-55.
14. Przegalinski, E., Filip, M. Nitric oxide (NO) pathway and locomotor hyper-activity towards dopaminomimetics in rats. Pol J Pharmacol 1997, 49: 291-8.
15. 2 receptor-dependent modulation of striatal NO synthase activity. Psychopharmacology 2007, 191: 793-803.
16. Ohno, M., Watanabe, S. Nitric oxide synthase inhibitors block behavioral sensitization to metamphetamine in mice. Eur J Pharmacol 1995, 275: 39-44.
17. Itzhak, Y. Modulation of cocaine- and metamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 1997, 282: 521-7.
18. 1 receptor interactions in the basal ganglia. Brain Res Brain Res Rev 1998, 26: 258-73.
19. 2 dopamine receptor antagonists block caffeine-induced stimulation of locomotor activity in rats. Pharmacol Biochem Behav 1994, 47: 89-94.
20. 1 receptors form functionally interacting heteromeric complexes. Proc Natl Acad Sci USA 2000, 97: 8606-11.
21. D-aspartate-stimulated hippocampal nitric oxide production in vivo. Stroke 1995, 26: 1627-33.
22. A receptor-channels. Neuropharmacology 1996, 35: 1365-74.
23. 2+ store in avian sensory neurons. J Neurophysiol 1993, 70: 710-22.
24. 3H]norepinephrine release. II. The role of calcium, reverse norepinephrine transport and cyclic 3′,5′-guanosine monophosphate. J Pharmacol Exp Ther 1995, 275: 14-22.
25. Del Bel, E.A., Guimarães, F.S., Bermúdez-Echeverry, M., Gomes, M.Z., Schiaveto-de-souza, A., Padovan-Neto, F.E., Tumas, V., Barion-Cavalcanti, A.P., Lazzarini, M., Nucci-da-Silva, L.P., de Paula-Souza, D. Role of nitric oxide on motor behavior. Cell Mol Neurobiol 2005, 25: 371-92.
26. Biasetti, M., Dawson, Jr.R. Effects of sulfur containing amino acids on iron and nitric oxide stimulated catecholamine oxidation. Amino Acids 2002, 22: 351-68.
27. Chepkova, A.N., Sergeeva, O.A., Haas, H.L. Long-lasting enhancement of corticostriatal transmission by taurine: Role of dopamine and acetyl-choline. Cell Mol Neurobiol 2005, 25: 767-76.
28. Evans, S.M., Griffiths, R.R. Caffeine withdrawal: A parametric analysis of caffeine dosing conditions. J Pharmacol Exp Ther 1999, 289: 285-94.
29. Bichler, A., Swenson, A., Harris, M.A. A combination of caffeine and taurine has no effect on short memory but induces changes in heart rate and mean arterial blood pressure. Amino Acids 2006, 31: 471-6.